• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number MDT-TRANS VALVE
Device Problem Material Split, Cut or Torn (4008)
Patient Problems Foreign Body Reaction (1868); Cusp Tear (2656); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 07/20/2022
Event Type  Injury  
Manufacturer Narrative
Citation: piotr nikodem rudzinski, markus mach, christoph gross, marco russo, paul werner, iuliana coti, sabine scherzer, martin andreas.Current prostheses for transcatheter heart valve replacement: a technical and clinical review.Rev.Cardiovasc.Med.2022, 23(8), 257.Https://doi.Org/10.31083/j.Rcm2308257 a copy of the article was not attached as digital sharing would be in violation of copyright permission.Earliest date of publication used for date of event.Medtronic products referenced: corevalve (product code npt, pma# p130021), evolut r (product code npt, pma# p130021), evolut pro (product code npt, pma# p130021), evolut pro+ (product code npt, pma# p130021).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product, no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Literature was reviewed regarding a technical and clinical review of current prostheses used for transcatheter aortic valve replacement (tavr).In figure 4, the authors presented an image and text concerning a surgically explanted self-expanding valve that appears to be a medtronic valve type (corevalve, evolut r, evolut pro, or evolut pro+).It was stated that the self-expanding valve showed structural valve deterioration in form of a commissural leaflet tear which led to severe transvalvular regurgitation, while pannus ingrowth was noted on the aortic side of the valve.The valve was explanted approximately 24 months after implantation.No further details were disclosed about this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC TRANSCATHETER VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key17043731
MDR Text Key316388380
Report Number2025587-2023-02290
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMDT-TRANS VALVE
Device Catalogue NumberMDT-TRANS VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/24/2023
Initial Date FDA Received06/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-